Article

Alcon to acquire WaveTec Vision, ORA System

Alcon Laboratories has entered into an agreement to acquire WaveTec Vision.

Fort Worth, TX-Alcon Laboratories has entered into an agreement to acquire WaveTec Vision.

Through the agreement, Alcon will also obtain full rights to WaveTec Vision’s ORA System, an intraoperative guidance system for cataract surgeons implanting IOLs.

More in this issue: Examining the impact of poor vision in a hospital setting

Alcon plans to integrate the guidance system into its existing cataract refractive suit, which includes:

·      Verion image-guided preoperative diagnostic system

·      LenSx femtosecond laser

·      Centurion phacoemulsification system

·      LuxOR LX3 microscrope

 

“Alcon is continuously seeking new ways to address the needs of cataract patients, particularly those who live with astigmatism and presbyopia,” said Jeff George, global head of Alcon. “The (guidance) system provides intraoperative measurements which are not available with current preoperative technologies and is designed to help surgeons improve patient outcomes through optimal IOL selection and placement during surgery.”

More in this issue: Allergan treatment for DME extended in EU

According to the company, the marriage of the guidance system and Alcon’s Verion imaged-guided system is intended to increase the surgeon’s clinical confidence when using IOLs. Ultimately, the combined technologies are designed to improve patient outcomes and enhance the overall post-surgical patient experience with IOLs.

“The (guidance) system has proven that there is real value in technology that is both patient- and provider-centered,” said Tom Frinzi, WaveTec president and chief executive officer.

Upon closing, Alcon will immediately begin the integration of the company into its surgical business franchise. The transaction is subject to closing conditions, including anti-trust approval.

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.